MC1989A1 - Composition proteique a activite antitumorale et/ou antivirale - Google Patents

Composition proteique a activite antitumorale et/ou antivirale

Info

Publication number
MC1989A1
MC1989A1 MC882019A MC2019A MC1989A1 MC 1989 A1 MC1989 A1 MC 1989A1 MC 882019 A MC882019 A MC 882019A MC 2019 A MC2019 A MC 2019A MC 1989 A1 MC1989 A1 MC 1989A1
Authority
MC
Monaco
Prior art keywords
cells
protein
protein composition
composition
virus
Prior art date
Application number
MC882019A
Other languages
English (en)
French (fr)
Inventor
Farkas-Himsley Hannah
Wyatt Henson Geoffroy
Charles Brooks Robert
Original Assignee
Univ Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Toronto filed Critical Univ Toronto
Publication of MC1989A1 publication Critical patent/MC1989A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MC882019A 1987-11-27 1988-11-25 Composition proteique a activite antitumorale et/ou antivirale MC1989A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12703287A 1987-11-27 1987-11-27

Publications (1)

Publication Number Publication Date
MC1989A1 true MC1989A1 (fr) 1989-11-30

Family

ID=22427981

Family Applications (1)

Application Number Title Priority Date Filing Date
MC882019A MC1989A1 (fr) 1987-11-27 1988-11-25 Composition proteique a activite antitumorale et/ou antivirale

Country Status (8)

Country Link
EP (1) EP0318302A1 (de)
JP (1) JPH01199594A (de)
AU (1) AU2591588A (de)
DK (1) DK661488D0 (de)
FI (1) FI885486A7 (de)
IL (1) IL88480A0 (de)
MC (1) MC1989A1 (de)
NO (1) NO885269L (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation
EP0213811A3 (de) * 1985-08-16 1987-09-09 Johnson Matthey, Inc., Bakteriozin-gerichtete Verbindungen zur Krebstherapie
IL82627A0 (en) * 1986-05-28 1987-11-30 Univ Toronto Bacteriocins and compositions thereof in anti-viral treatment

Also Published As

Publication number Publication date
NO885269L (no) 1989-05-29
FI885486A0 (fi) 1988-11-25
JPH01199594A (ja) 1989-08-10
FI885486L (fi) 1989-05-28
AU2591588A (en) 1989-09-07
FI885486A7 (fi) 1989-05-28
EP0318302A1 (de) 1989-05-31
DK661488D0 (da) 1988-11-25
NO885269D0 (no) 1988-11-25
IL88480A0 (en) 1989-06-30

Similar Documents

Publication Publication Date Title
US10266573B2 (en) Cytotoxic factors for modulating cell death
Liu et al. Eosinophilic colitis associated with larvae of the pinworm Enterobius vermicularis
JPH08510997A (ja) 幹細胞増殖インヒビターおよびその使用
Benoit et al. Pure endotoxin does not pass across the intestinal epithelium in vitro
JPH02111725A (ja) 医薬組成物
JPH09511220A (ja) バクテリアによって誘発される炎症性疾患の治療
TW202106313A (zh) 用於治療敗血症或全身性發炎反應症候群的包含經單離之粒線體作為有效成分的藥學組成物
KR920002935B1 (ko) 맥관 형성 저해제
KR20070097423A (ko) 흉선-특이성 단백질
NO173655B (no) Fremgangsmaate for ekstrahering av et tetrapeptid fra biologisk materiale
US4861754A (en) Bacteriocins and compositions thereof in anti-viral treatment
CN113024400A (zh) 一种秋水仙碱衍生物及其制备方法和应用
MC1822A1 (fr) Bacteriocines et compositions antivirales les contenant
JP2816564B2 (ja) 乳酸菌調製物
EP0352146A1 (de) Aus Gingko Biloba extrahierter biologischer Regulator, wirksam in verschiedenen Pathologien.
Fujimura et al. Neutrophil-mediated tumor cell destruction in cancer ascites: II. A OK-432 attracts killer neutrophils through activation of complement C5
EP0295962B1 (de) Proteinhaltiges Polysaccharid zur Behandlung retroviraler Infektionen
KR102926018B1 (ko) 병원성 대장균의 증식을 억제하기 위한 조성물 및 방법
JP2000336038A (ja) 肝臓保護剤
FR2466454A1 (fr) Peptides ayant des proprietes immunostimulantes et compositions pharmaceutiques les contenant
WO2007062150A2 (en) Leukotoxin compositions and therapeutic methods
FR2550707A1 (fr) Medicament immunomodulateur d'origine biologique et son procede de preparation
EP0308279A1 (de) Wasserlösliche Polysaccharide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikamente und dieses enthaltendes Präparat
NO885269L (no) Proteinholdige sammensetninger.
WO2005123107A2 (en) Immune response suppressor and treatment of multiple sclerosis

Legal Events

Date Code Title Description
YP Annual fee paid